Johnson & Johnson said Tuesday that Phase 3 studies show that a booster shot of its COVID-19 vaccine increases protection against moderate cases of the virus to 94% in the U.S. Worldwide, J&J said ...
The FDA and CDC recommended Pfizer booster shots for some groups, including elderly people, this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback